Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC).

Leigh syndrome French Canadian type cardiomyocyte cells disease modeling hepatocyte-like cells induced pluripotent stem cells three germ layers

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2024
Historique:
received: 23 01 2024
accepted: 02 04 2024
medline: 6 5 2024
pubmed: 6 5 2024
entrez: 6 5 2024
Statut: epublish

Résumé

Leigh syndrome French Canadian type (LSFC) is a recessive neurodegenerative disease characterized by tissue-specific deficiency in cytochrome c oxidase (COX), the fourth complex in the oxidative phosphorylation system. LSFC is caused by mutations in the leucine rich pentatricopeptide repeat containing gene (

Identifiants

pubmed: 38706791
doi: 10.3389/fgene.2024.1375467
pii: 1375467
pmc: PMC11066297
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1375467

Informations de copyright

Copyright © 2024 Gélinas, Lévesque, Thompson Legault, Rivard, Villeneuve, Laprise and Rioux.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Roselle Gélinas (R)

Montreal Heart Institute, Montreal, QC, Canada.

Chloé Lévesque (C)

Montreal Heart Institute, Montreal, QC, Canada.

Julie Thompson Legault (J)

Montreal Heart Institute, Montreal, QC, Canada.

Marie-Eve Rivard (ME)

Montreal Heart Institute, Montreal, QC, Canada.

Louis Villeneuve (L)

Montreal Heart Institute, Montreal, QC, Canada.

Catherine Laprise (C)

Université du Québec à Chicoutimi, Saguenay, QC, Canada.

John D Rioux (JD)

Montreal Heart Institute, Montreal, QC, Canada.
Université de Montréal, Montreal, QC, Canada.

Classifications MeSH